| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/13/1998 | EP0668872B1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 05/13/1998 | EP0662971B1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM |
| 05/13/1998 | EP0660707A4 Method of preventing nmda receptor-mediated neuronal damage. |
| 05/13/1998 | EP0623118B1 Carbamate derivatives and their use in medicine |
| 05/13/1998 | CN1181753A Novel substituted piperazine derivatives having tachyknin receptor antagonists activity |
| 05/13/1998 | CN1181704A Use of glial neurotrophic factor (GDND) for treatment of hearing disorders |
| 05/13/1998 | CN1181700A Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 05/13/1998 | CN1181263A Auxiliary tablet and aspirin in application for treating mental retardation |
| 05/12/1998 | US5750724 Indolealkyl derivatives of benzodioxanmethylamine |
| 05/12/1998 | US5750720 Alpha-adrenoreceptors and central nervous systems |
| 05/12/1998 | US5750712 Diabetic therapy |
| 05/12/1998 | US5750560 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives |
| 05/12/1998 | US5750555 Bis-indolyl maleinimide or indolopyrrolo carbazole containing an amino acid as PKC inhibitors |
| 05/12/1998 | US5750554 Compounds for treatment of anxiety, depression, antisecretory agents, hypotensive agents and treatment of eating problems |
| 05/12/1998 | US5750526 Pyrido 1,2,3-DE!quinoxaline derivatives, process for their production and their use in pharmaceutical agents |
| 05/12/1998 | US5750525 Antagonists of excitatory amino acids used for treatment of neurological and psychiatric disorders |
| 05/12/1998 | US5750521 Mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
| 05/12/1998 | US5750518 Administering to treat diabetic neuropathy, migraine, neurogenic inflammation and rheumatoid arthritis |
| 05/12/1998 | US5750512 For treatment of parkinson's and alzheimer's disease or mental depression |
| 05/12/1998 | US5750398 Vector, element and method for inhibiting immune recognition |
| 05/12/1998 | US5750140 Transdermal delivery of tiagabine |
| 05/12/1998 | CA2030718C Tricyclic compounds |
| 05/12/1998 | CA2010312C Peptide derivatives and their pharmaceutical use |
| 05/08/1998 | CA2220996A1 New aminomethyl heterocyclic derivatives, their preparation process and the pharmaceutical compositions they contain |
| 05/07/1998 | WO1998019165A1 A method for the identification of compounds with anxiolytic potential |
| 05/07/1998 | WO1998018934A1 Therapeutic gene |
| 05/07/1998 | WO1998018925A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids |
| 05/07/1998 | WO1998018919A2 Gabaa receptor subunit epsilon-related protein |
| 05/07/1998 | WO1998018816A1 Peptide compositions with growth factor-like activity |
| 05/07/1998 | WO1998018803A1 Novel (alpha-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof |
| 05/07/1998 | WO1998018798A1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
| 05/07/1998 | WO1998018797A1 2-methoxyphenylpiperazine derivatives |
| 05/07/1998 | WO1998018793A1 Benzoxazole derivative with an affinity to binding sites of amino acid receptors |
| 05/07/1998 | WO1998018792A1 THIENYLCYCLOHEXANONE DERIVATIVES AS LIGANDS OF THE GABAA α5 RECEPTOR SUBTYPE |
| 05/07/1998 | WO1998018788A1 Piperazino derivatives as neurokinin antagonists |
| 05/07/1998 | WO1998018786A1 Constrained somatostatin agonists and antagonists |
| 05/07/1998 | WO1998018785A1 Substituted oximes derivatives useful as neurokinin antagonists |
| 05/07/1998 | WO1998018779A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | WO1998018778A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | WO1998018777A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | WO1998018776A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | WO1998018775A1 Novel (+)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | WO1998018774A1 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | WO1998018773A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | WO1998018772A1 NOVEL cis-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 05/07/1998 | WO1998018771A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | WO1998018769A1 Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use as noncompetitive antagonists of dopamine reuptake |
| 05/07/1998 | WO1998018761A1 Substituted arylalkylamines as neurokinin antagonists |
| 05/07/1998 | WO1998018759A1 Vitamin d analogues |
| 05/07/1998 | WO1998018466A2 Anti-neurogenic inflammatory compounds and compositions and methods of use thereof |
| 05/07/1998 | WO1998018457A1 Use of adamantane amines or structurally similar compounds for combating borna disease virus and for the prevention and treatment of affective diseases and other disorders associated with bdv infections in humans and animals |
| 05/07/1998 | WO1998011243A3 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein |
| 05/07/1998 | WO1998009985A3 Anti-inflammatory peptides and uses thereof |
| 05/07/1998 | WO1998008965A3 Cd95 regulatory gene sequences and transcription factors |
| 05/07/1998 | WO1998006841A3 Two human nsp-like proteins |
| 05/07/1998 | WO1998000173A3 Targeted drug delivery using sulfonamide derivatives |
| 05/07/1998 | DE19643790A1 Benzoxazol-Derivat Benzoxazole derivative |
| 05/07/1998 | CA2270359A1 Benzoaxozole derivative |
| 05/07/1998 | CA2270113A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2270111A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2270057A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2270056A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2270055A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2269974A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2269973A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2269970A1 Novel (+)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2269936A1 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2269814A1 2-methoxyphenylpiperazine derivatives |
| 05/07/1998 | CA2269642A1 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids |
| 05/07/1998 | CA2269328A1 Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use as noncompetitive antagonists of dopamine reuptake |
| 05/07/1998 | CA2268838A1 Thienylcyclohexanone derivatives as ligands of the gabaa .alpha.5 receptor subtype |
| 05/07/1998 | CA2266514A1 Novel (alpha-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof |
| 05/06/1998 | EP0839149A1 Galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 05/06/1998 | EP0839148A1 (r)-(z)-1-azabicyclo 2.2.1]heptan-3-one,o- 3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent |
| 05/06/1998 | EP0839146A1 Piperazine derivatives and their use as 5-ht1a antagonists |
| 05/06/1998 | EP0839145A1 Heterocyclylcarboxamide derivatives and their use as therapeutic agents |
| 05/06/1998 | EP0839144A1 Piperazine derivatives as therapeutic agents |
| 05/06/1998 | EP0839137A1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 05/06/1998 | EP0839136A1 BENZO[g]QUINOLINE DERIVATIVES |
| 05/06/1998 | EP0839134A1 Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| 05/06/1998 | EP0839041A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 05/06/1998 | EP0839039A1 Paroxetine controlled release compositions |
| 05/06/1998 | EP0839032A1 Hydroxyl ions as unique therapeutic agents and compounds that modulate ions, compounds |
| 05/06/1998 | EP0707570B1 Isoquinoline derivatives as therapeutic agents |
| 05/06/1998 | EP0705254B1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 05/06/1998 | EP0671908B1 Pharmaceutical compositions comprising 5-ht 1? receptor agonists and absorption enhancers |
| 05/06/1998 | CN1181084A Tricyclic benzazepine vasopression antagonists |
| 05/06/1998 | CN1181081A Anellated 'beta' -carbolines |
| 05/06/1998 | CN1181075A Substituted isoxazoles for the treatment of inflammation |
| 05/06/1998 | CN1181070A Bicyclic isothiourea derivatives useful in therapy |
| 05/06/1998 | CN1181064A O-carbamoyl-phenylalaninol having substituent at benzene ring ,its pharmaceutically useful salts and method for preparing the same |
| 05/06/1998 | CN1181015A Reduction of infarct volume using citicoline |
| 05/06/1998 | CN1181007A Preparation for absorbing transmission from skin |
| 05/05/1998 | US5747655 Nerve cells, geonomes dna sequences and amino acid sequences |
| 05/05/1998 | US5747524 Cannabinoid receptor antagonists |
| 05/05/1998 | US5747517 Benzylidene rhodanines |
| 05/05/1998 | US5747515 Heterocyclic compounds and compositions having nevropharmacological potential |
| 05/05/1998 | US5747503 Indeno(1,2b)pyroles |
| 05/05/1998 | US5747501 Indole derivatives |
| 05/05/1998 | US5747492 Heteroatom substituted benzoyl derivatives that enhance synaptic responses mediated by ampa receptors |